Javascript must be enabled to continue!
P191 MINIMALLY-INVASIVE ESOPHAGECTOMY IN TREATMENT FOR ESOPHAGEAL DISEASES
View through CrossRef
Abstract
Aim
to study the benefits of the mini-invasive approach.
Background & Methods
115 esophagectomies were performed for the period from 2015 to 2018. Gastric conduit in 84 patients, colon - 2 and small intestine - 29. The study included 65 patients after I.Lewis, McKeown or transhiatal esophagectomy, who was performed esophageal replacement with gastric conduit. The first group consisted of 44 patients after open esophagectomy; second group - 21 patients after MIE (minimally invasive esophagectomy): included 8 patients - thoraco-laparoscopic McKeown surgery, 1 patient - laparoscopic transhiatal esophagectomy with anastomosis on the neck, 9 patients – hybrid minimally invasive I.Lewis surgery (laparoscopy+thoracotomy), and 3 patients – minimally invasive thoraco-laparoscopic I.Lewis surgery. The average age of patients was 53 years (13-64). 55 patients (84.6%) with esophageal cancer and 10 patients (15.4%) with benign strictures of the esophagus. There were anastomosis on the neck in 28 patients (43%) and intrathoracic anastomosis in 37 patients (57%).
Results
In the first group the average operative time was 286 minutes (240-370 min.), the average volume of blood loss was 345 ml (100-600 ml), the length of in-hospital stay was 15 days (9-29), complications: anastomosis leakage - 1 patient on the 5th postoperative day - EndoVAC system was used with a defect closure after 18 days; 1 patient - adhesive intestinal obstruction (relaparotomy, separation of adhesions). In the second group the average operative time was 400 min (370-480 min.), blood loss - 100 ml (50-200 ml), the length of in-hospital stay - 10 days (8-16), complications in 1 patient - acute strangulation with intestinal obstruction. There was no mortality in both groups.
Conclusions
The application of MIE helps to reduce the severity of postoperative pain, the length of in-hospital stay and intraoperative blood loss. This procedure should be performed in specialized hospitals with experience in miniinvasive surgery and esophageal surgery.
Oxford University Press (OUP)
Title: P191 MINIMALLY-INVASIVE ESOPHAGECTOMY IN TREATMENT FOR ESOPHAGEAL DISEASES
Description:
Abstract
Aim
to study the benefits of the mini-invasive approach.
Background & Methods
115 esophagectomies were performed for the period from 2015 to 2018.
Gastric conduit in 84 patients, colon - 2 and small intestine - 29.
The study included 65 patients after I.
Lewis, McKeown or transhiatal esophagectomy, who was performed esophageal replacement with gastric conduit.
The first group consisted of 44 patients after open esophagectomy; second group - 21 patients after MIE (minimally invasive esophagectomy): included 8 patients - thoraco-laparoscopic McKeown surgery, 1 patient - laparoscopic transhiatal esophagectomy with anastomosis on the neck, 9 patients – hybrid minimally invasive I.
Lewis surgery (laparoscopy+thoracotomy), and 3 patients – minimally invasive thoraco-laparoscopic I.
Lewis surgery.
The average age of patients was 53 years (13-64).
55 patients (84.
6%) with esophageal cancer and 10 patients (15.
4%) with benign strictures of the esophagus.
There were anastomosis on the neck in 28 patients (43%) and intrathoracic anastomosis in 37 patients (57%).
Results
In the first group the average operative time was 286 minutes (240-370 min.
), the average volume of blood loss was 345 ml (100-600 ml), the length of in-hospital stay was 15 days (9-29), complications: anastomosis leakage - 1 patient on the 5th postoperative day - EndoVAC system was used with a defect closure after 18 days; 1 patient - adhesive intestinal obstruction (relaparotomy, separation of adhesions).
In the second group the average operative time was 400 min (370-480 min.
), blood loss - 100 ml (50-200 ml), the length of in-hospital stay - 10 days (8-16), complications in 1 patient - acute strangulation with intestinal obstruction.
There was no mortality in both groups.
Conclusions
The application of MIE helps to reduce the severity of postoperative pain, the length of in-hospital stay and intraoperative blood loss.
This procedure should be performed in specialized hospitals with experience in miniinvasive surgery and esophageal surgery.
Related Results
063. ROBOTIC ASSISTED MIMINALLY INVASIVE IVOR-LEWIS ESOPHAGECTOMY VERSUS CONVENTIONAL MINIMALLY INVASIVE IVOR-LEWIS ESOPHAGECTOMY
063. ROBOTIC ASSISTED MIMINALLY INVASIVE IVOR-LEWIS ESOPHAGECTOMY VERSUS CONVENTIONAL MINIMALLY INVASIVE IVOR-LEWIS ESOPHAGECTOMY
Abstract
Background
Minimally invasive technique for esophagectomy has emerged as the standard of care for resectable esophageal...
Prognostic factors influencing morbidity and mortality in esophageal carcinoma
Prognostic factors influencing morbidity and mortality in esophageal carcinoma
PURPOSE: In 1980, operative mortality for esophageal resection was 29%. Over the last 15 years, technical and critical care improvements contributed to the reduction of postoperati...
P53 MINIMALLY INVASIVE TECHNIQUES FOR TRANSTHORACIC ESOPHAGECTOMY FOR ESOPHAGEAL CANCERS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
P53 MINIMALLY INVASIVE TECHNIQUES FOR TRANSTHORACIC ESOPHAGECTOMY FOR ESOPHAGEAL CANCERS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
Abstract
Aim
To evaluate the clinical outcomes for open, minimally invasive and robotic esophagectomy techniques for esophageal ...
022. TREATMENT EXPERIENCE OF ESOPHAGEAL FISTULA INDUCED BY NEOADJUVANT THERAPY IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A SINGLE-CENTER EXPERIENCE
022. TREATMENT EXPERIENCE OF ESOPHAGEAL FISTULA INDUCED BY NEOADJUVANT THERAPY IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A SINGLE-CENTER EXPERIENCE
Abstract
Background
Esophageal squamous cell carcinoma (ESCC) is typically treated with neoadjuvant therapy followed by esophage...
FA01.01: MINIMALLY INVASIVE APPROACH RESULTS IN BETTER OUTCOME COMPARED TO OPEN ESOPHAGECTOMY—A PROPENSITY SCORE MATCHED ANALYSIS
FA01.01: MINIMALLY INVASIVE APPROACH RESULTS IN BETTER OUTCOME COMPARED TO OPEN ESOPHAGECTOMY—A PROPENSITY SCORE MATCHED ANALYSIS
Abstract
Background
Esophagectomy remains the mainstay treatment for esophageal cancer. Minimally invasive techniques have gaine...
The analysis on Tiam2 for expression in esophageal carcinoma: A descriptive study
The analysis on Tiam2 for expression in esophageal carcinoma: A descriptive study
Rationale:
To investigate T lymphoma invasion and metastasis inducing factor 2 (Tiam2) protein for expression in esophageal carcinoma and relationship with clinical fea...
Robot-assisted thoracoscopic esophagectomy versus thoracoscopic esophagectomy
Robot-assisted thoracoscopic esophagectomy versus thoracoscopic esophagectomy
Abstract
Background
The gold standard for treating resectable esophageal cancer is esophagectomy. Robot-assisted thoracoscopic esophagectomy (RATE) is a technique that bri...
Salvage Esophagectomy in Advanced Esophageal Cancer
Salvage Esophagectomy in Advanced Esophageal Cancer
Even through the esophageal cancer has innumerable treatment options, its prognosis is still unsettled. Because esophagectomy is rarely curative, others therapies, such as chemorad...

